GEC-ESTRO ACROP 关于医院层面高剂量率-脉冲剂量率光子源近距离放疗源校准与溯源的建议
该建议由 GEC-ESTRO BRAPHYQS 工作组第21工作包(WP-21)制定,聚焦高剂量率-脉冲剂量率(HDR-PDR)近距离放疗源的校准与溯源,补充 WP-18 报告未涵盖的实践问题,旨在建立欧洲统一的医院层面校准标准以维持高质量患者治疗。
要点
- 建议针对光子能量高于50 keV的HDR-PDR临时植入源在医院层面的校准与溯源。
- 由 GEC-ESTRO BRAPHYQS 工作组第21工作包(WP-21)制定,补充 WP-18 低能种子源报告。
- 目标为建立欧洲统一的 HDR-PDR 近距离放疗源校准标准以维持高质量治疗。
核心结论
- 报告旨在提供欧洲统一的医院层面 HDR-PDR 近距离放疗源校准标准,以维持高质量患者治疗。
研究设计与样本
- 由 GEC-ESTRO BRAPHYQS 工作组第21工作包(WP-21)制定的建议文件,聚焦 HDR-PDR 源校准。
关键数值与推荐
- 建议涵盖光子能量高于50 keV的 HDR-PDR 临时植入源在医院层面的校准与溯源指导。
- 建议补充 BRAPHYQS WP-18 低能近距离放疗光子发射源(种子)报告未具体涵盖的实践方面与问题。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The vast majority of radiotherapy departments in Europe using brachytherapy (BT) perform temporary implants of high- or pulsed-dose rate (HDR-PDR) sources with photon energies higher than 50 keV. Such techniques are successfully applied to diverse pathologies and clinical scenarios. These recommendations are the result of Working Package 21 (WP-21) initiated within the BRAchytherapy PHYsics Quality Assurance System (BRAPHYQS) GEC-ESTRO working group with a focus on HDR-PDR source calibration. They provide guidance on the calibration of such sources, including practical aspects and issues not specifically accounted for in well-accepted societal recommendations, complementing the BRAPHYQS WP-18 Report dedicated to low energy BT photon emitting sources (seeds). The aim of this report is to provide a European-wide standard in HDR-PDR BT source calibration at the hospital level to maintain high quality patient treatments.
引用
- Perez-Calatayud J, Ballester F, Carlsson Tedgren Å, et al. GEC-ESTRO ACROP recommendations on calibration and traceability of HE HDR-PDR photon-emitting brachytherapy sources at the hospital level. Radiother Oncol. 2022. PMID: 36167195. doi:10.1016/j.radonc.2022.09.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。